arecoline has been researched along with sabcomeline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bromidge, SM; Brown, F; Cassidy, F; Clark, MS; Dabbs, S; Hadley, MS; Hawkins, J; Loudon, JM; Naylor, CB; Orlek, BS; Riley, GJ | 1 |
Dei, S; Marconi, C; Pedretti, A; Romanelli, MN; Scapecchi, S; Vistoli, G | 1 |
2 other study(ies) available for arecoline and sabcomeline
Article | Year |
---|---|
Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.
Topics: Alzheimer Disease; Animals; Binding Sites; Blood Pressure; Brain; CHO Cells; Cricetinae; Electroencephalography; Heart Rate; Humans; Imines; Magnetic Resonance Spectroscopy; Male; Models, Molecular; Molecular Structure; Muscarinic Agonists; Protein Binding; Quinuclidines; Rats; Rats, Inbred Strains; Receptor, Muscarinic M1; Receptors, Muscarinic; Recombinant Proteins; Stereoisomerism; Tremor | 1997 |
Docking analyses on human muscarinic receptors: unveiling the subtypes peculiarities in agonists binding.
Topics: Binding Sites; Computer Simulation; Humans; Ligands; Muscarinic Agonists; Protein Binding; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptor, Muscarinic M5; Receptors, Muscarinic | 2008 |